InsiderTrades

Form 4 for IBRX ImmunityBio, Inc.

Accepted 2026-07-06 20:25:29 ET · period of report 2026-07-01 · accession 0001849739-26-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-07-06 20:25 2026-07-01 IBRX Selecky Christobel Dir M - OptEx $2.99 +159.5K 159.5K New +$476.5K
DT 2026-07-06 20:25 2026-07-01 IBRX Selecky Christobel Dir S - Sale+OE $9.02 -159.5K 0 -100% -$1.44M
DMT 2026-07-06 20:25 2026-07-01 IBRX Selecky Christobel Dir M - OptEx $0.00 -159.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-01 M A 35,064 $2.98 35,064 D — —
2 Common Common Stock 2026-07-01 M A 124,414 $2.99 159,478 D — —
3 Common Common Stock 2026-07-01 S D 159,478 $9.02 0 D — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) Represents the weighted average share price of an aggregate total of 159,478 shares sold in the price range of $9.00 to $9.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2026-07-01 M D 35,064 $0.00 0 D $2.98 · 2023-06-12 to 2032-06-14 35,064 Common Stock
5 Derivative Stock Option (right to buy) 2026-07-01 M D 124,414 $0.00 0 D $2.99 · 2024-06-10 to 2033-06-13 124,414 Common Stock